Drugs of Abuse (DOA) Testing Market Report 2026

Drugs of Abuse (DOA) Testing Market Overview

• Drugs of Abuse (DOA) Testing market size has reached to $7.97 billion in 2025 • Expected to grow to $12.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Rising Demand For Drug Abuse Treatment Drives Growth In The DOA Testing Market • Market Trend: Innovative Solutions In The Drugs Of Abuse Testing Market Are Software-As-A-Service (SAAS) Platforms For Enhanced Drug Discovery And Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drugs of Abuse (DOA) Testing Market?

Drug of abuse (DOA) testing refers to the examination of a substance, such as a drug, chemical, or plant product, that is usually treated recreationally. It includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are tested for on a drug panel. The patient's urine, saliva, blood, hair, or sweat are used in this clinical screening procedure. The main products and services for drug of abuse (DOA) testing are analyzers, rapid testing devices, consumables, and laboratory services. An analyzer is a device that automatically measures the chemical concentration of one or more components or another associated physical quantity, continuously or intermittently. There are sample types included such as urine, hair, oral fluid, and breath, and are available in various applications such as pain management, criminal justice, and workplace screening. The end users involve hospitals, diagnostic laboratories, forensic laboratories, and others.

What Is The Drugs of Abuse (DOA) Testing Market Growth Forecast?

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $12.17 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to remote workplace testing demand, oral fluid testing growth, real-time data integration, regulatory enforcement expansion, public health monitoring programs. Major trends in the forecast period include rising adoption of workplace drug screening programs, growing demand for rapid point-of-care testing, expansion of multi-panel drug testing kits, increased use of laboratory confirmation testing, integration of digital reporting and data management.

Global Drugs of Abuse (DOA) Testing Market Segmentation

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services 2) By Sample Type: Urine, Hair, Oral Fluid, Breath 3) By Application: Pain Management, Criminal Justice, Workplace Screening 4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users Subsegments: 1) By Analyzers: Immunoassay Analyzers, Chromatography-Based Analyzers, Mass Spectrometry Systems 2) By Rapid Testing Devices: Urine Test Kits, Saliva Test Kits, Hair Test Kits 3) By Consumables: Test Strips, Reagents, Sample Collection Devices 4) By Laboratory Services: Toxicology Testing, Confirmation Testing, Screening Services

What Is The Driver Of The Drugs of Abuse (DOA) Testing Market?

Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in December 2023, the Government of the United Kingdom (GOV. UK), a UK-based government platform, reported that between April 2022 and March 2023, 290,635 adults accessed drug and alcohol services, a slight increase from 289,215 in the previous year. Treatment admissions also rose to 137,749, compared to 130,490 and 133,704 in the prior two years. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Key Players In The Global Drugs of Abuse (DOA) Testing Market

Major companies operating in the drugs of abuse (doa) testing market are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

Global Drugs of Abuse (DOA) Testing Market Trends and Insights

Major companies operating in the drugs of abuse (DOA) testing market are focusing on developing innovative products such as software-as-a-service (SaaS) platforms to enhance testing efficiency, improve data management, and strengthen their competitive position. A software-as-a-service (SaaS) platform refers to a cloud-based application hosted by a third-party provider and accessed via the internet, enabling users to streamline workflows, analyze complex datasets, and gain actionable insights without the need for local software installation. For instance, in December 2023, Merck KGaA, a US-based science and technology company, launched Addison, an advanced drug discovery software platform that integrates computer-aided drug design, machine learning, and generative AI to accelerate drug development. The platform provides synthesis recommendations for virtual molecules, connects digital drug design with practical manufacturability, and uncovers hidden insights from large datasets, ultimately increasing the likelihood of delivering effective new therapies to patients.

What Are Latest Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market?

In June 2024, Premier Biotech Inc., a US-based biotechnology company, acquired Desert Tox LLC for an undisclosed amount. Through this acquisition, Premier Biotech aims to broaden its portfolio of affordable drug misuse screening solutions and improve the accessibility and effectiveness of drug testing services. Desert Tox LLC is a US-based company specializing in toxicology and drug testing solutions.

Regional Outlook

North America was the largest region in the drugs of abuse (DOA) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drugs of Abuse (DOA) Testing Market?

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drugs of Abuse (DOA) Testing Market Report 2026?

The drugs of abuse (doa) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (doa) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.